Paper3065243
Clinical experience with ciprofloxacin in the treatment of urinary tract infections: a review.
van Poppel H and 3 others. Infection, 1988. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Clinical experience with ciprofloxacin in the treatment of urinary tract infections: a review. Papers, record 3065243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3065243
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clinical experience with ciprofloxacin in the treatment of urinary tract infections: a review.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ciprofloxacin | Major topic |
| Enterobacteriaceae Infections | Major topic |
| Urinary Tract Infections | Major topic |
| Adult | |
| Aged | |
| Bacteriuria | |
| Female | |
| Humans | |
| Male | |
| Microbial Sensitivity Tests | |
| Middle Aged |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2941294 | Ciprofloxacin in the treatment of urinary tract infection in patients with multiple sclerosis. | Eur J Clin Microbiol | 1986 | https://conductscience.org/library/papers/2941294 | PubMed |
| 2 | 3555042 | Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections. | Am J Med | 1987 | https://conductscience.org/library/papers/3555042 | PubMed |
| 3 | 3542946 | The mode of action of 4-quinolones and possible mechanisms of resistance. | J Antimicrob Chemother | 1986 | https://conductscience.org/library/papers/3542946 | PubMed |
| 4 | 2933381 | Efficacy and safety of ciprofloxacin (Bay 0 9867) in the treatment of patients with complicated urinary tract infections. | J Antimicrob Chemother | 1985 | https://conductscience.org/library/papers/2933381 | PubMed |
| 5 | 3542943 | Ciprofloxacin therapy in complicated urinary tract infections caused by Pseudomonas aeruginosa and other resistant bacteria. | J Antimicrob Chemother | 1986 | https://conductscience.org/library/papers/3542943 | PubMed |
| 6 | 6228192 | In vitro activity of ciprofloxacin (Bay o 9867). | Antimicrob Agents Chemother | 1983 | https://conductscience.org/library/papers/6228192 | PubMed |
| 7 | 3804903 | Treatment of skin and soft tissue infections with oral ciprofloxacin. | J Antimicrob Chemother | 1986 | https://conductscience.org/library/papers/3804903 | PubMed |
| 8 | 3804900 | The efficacy and safety of ciprofloxacin in the treatment of chronic Pseudomonas aeruginosa urinary tract infection. | J Antimicrob Chemother | 1986 | https://conductscience.org/library/papers/3804900 | PubMed |
| 9 | 6237904 | Mutational resistance to 4-quinolone antibacterial agents. | Eur J Clin Microbiol | 1984 | https://conductscience.org/library/papers/6237904 | PubMed |
| 10 | 3492486 | Comparison of ciprofloxacin and co-trimoxazole in the treatment of uncomplicated urinary tract infection in women. | J Antimicrob Chemother | 1986 | https://conductscience.org/library/papers/3492486 | PubMed |
| 11 | 3013631 | Overview of clinical experience with ciprofloxacin. | Eur J Clin Microbiol | 1986 | https://conductscience.org/library/papers/3013631 | PubMed |
| 12 | 2941286 | Clinical experience with ciprofloxacin in the USA. | Eur J Clin Microbiol | 1986 | https://conductscience.org/library/papers/2941286 | PubMed |
| 13 | 16312452 | Biotyping and susceptibility behaviour of pathogens in patients treated with ciprofloxacin. | J Chemother | 1989 | https://conductscience.org/library/papers/16312452 | PubMed |
| 14 | 3542942 | A comparative study of ciprofloxacin and trimethoprim in the treatment of urinary tract infections in geriatric patients. | J Antimicrob Chemother | 1986 | https://conductscience.org/library/papers/3542942 | PubMed |
| 15 | 3468100 | The comparative in-vitro activity of eight newer quinolones and nalidixic acid. | J Antimicrob Chemother | 1986 | https://conductscience.org/library/papers/3468100 | PubMed |
| 16 | 3100490 | Ciprofloxacin in the treatment of Pseudomonas infection in cystic fibrosis patients. | J Antimicrob Chemother | 1986 | https://conductscience.org/library/papers/3100490 | PubMed |
| 17 | 6222695 | In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents. | Antimicrob Agents Chemother | 1983 | https://conductscience.org/library/papers/6222695 | PubMed |
| 18 | 2941288 | Evaluation of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections. | Eur J Clin Microbiol | 1986 | https://conductscience.org/library/papers/2941288 | PubMed |
| 19 | 3325932 | Treatment of multi-resistant urinary tract infections in patients with multiple sclerosis. | Pharm Weekbl Sci | 1987 | https://conductscience.org/library/papers/3325932 | PubMed |
| 20 | 2936583 | Oral treatment of Pseudomonas-induced urinary tract infections with ciprofloxacin. | Chemotherapy | 1986 | https://conductscience.org/library/papers/2936583 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 26848334 | Susceptibility pattern of uropathogens to ciprofloxacin at the Ghana police hospital. | Pan Afr Med J | 2015 | https://conductscience.org/library/papers/26848334 | PubMed |
| 21984270 | Susceptibility of Pseudomonas aeruginosa urinary tract isolates and influence of urinary tract conditions on antibiotic tolerance. | Curr Microbiol | 2012 | https://conductscience.org/library/papers/21984270 | PubMed |
| 16856014 | Quinolones for uncomplicated acute cystitis in women. | Cochrane Database Syst Rev | 2006 | https://conductscience.org/library/papers/16856014 | PubMed |
| 12843075 | Detection and identification of ciprofloxacin-resistant Yersinia pestis by denaturing high-performance liquid chromatography. | J Clin Microbiol | 2003 | https://conductscience.org/library/papers/12843075 | PubMed |
| 10146890 | Oral ciprofloxacin: a pharmacoeconomic evaluation of its use in the treatment of serious infections. | Pharmacoeconomics | 1993 | https://conductscience.org/library/papers/10146890 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3065243
GET https://conductscience.org/api/papers/v1/3065243/references?page=2